Comparison between on-label versus off-label use of drug-eluting coronary stents in clinical practice: results from the German DES.DE-Registry
Observational studies from the USA have demonstrated that off-label use of drug-eluting stents (DES) is common. Data on off-label use in Western Europe are limited.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
18 March 2011
|
| In: |
Clinical research in cardiology
Year: 2011, Jahrgang: 100, Heft: 8, Pages: 701-709 |
| ISSN: | 1861-0692 |
| DOI: | 10.1007/s00392-011-0301-8 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00392-011-0301-8 |
| Verfasserangaben: | Timm Bauer, Christoph A. Nienaber, Ibrahim Akin, Karl-Heinz Kuck, Matthias Hochadel, Jochen Senges, Thomas Fetsch, Ulrich Tebbe, Stefan N. Willich, Jürgen Stumpf, Georg V. Sabin, Sigmund Silber, Gert Richardt, Ralf Zahn for the DES.DE Study Group |